Supplementary Information
All solvents and buffers used for HPLC analyses were purchased through VWR International and were HPLC or ACS grade. Chemical Water was obtained from a Barnstead Nanopure Infinity Ultrapure system maintained within our laboratories. Commercially available hops extracts (Hopsteiner) were used for the isolation/preparation of individual hop acids. The chemicals used as bases for crystallization were purchased from Sigma Aldrich Chemical and used without further purification. Authentic hops standards were provided by the American Society of Brewing Chemists. Further structural confirmation was provided via specific rotation, melting point, NMR, UV, and UPLC-MS/MS when compared to preceding literature reports as available.
SI1.2 Analytical Instrumentation
NMR spectra were recorded at 298 K on a Bruker AV300, AV500, DRX500 and/or Varian INOVA 500, or 600 spectrometers. 1 H-NMR chemical shifts are reported versus TMS and referenced to residual solvent. Elemental analyses and specific rotation measurements were performed by Robertson Microlit Laboratories (Madison, NY) utilizing a Perking-Elmer 341-Polarimeter. All reactions/purifications were monitored by HPLC and/or UPLC-MS/MS. HPLC analyses were performed using a Shimadzu Prominence HPLC system (Shimadzu Scientific Instruments, Inc.). Suitable non-chiral reverse-phase chromatography and chiral normal-phase chromatography methods used for chemical and/or reaction evaluation by HPLC are presented in Tables SI-1 and SI-2 respectively. UPLC-MS/MS analyses were performed using a Shimadzu Nexera UPLC system (Shimadzu Scientific Instruments, Inc.) connected to an API-2000 MS/MS (ABSciex). All UPLC conditions can be seen in Table SI -3. All fragmentation information was acquired using information dependent acquisition (IDA) in negative mode (M-H) and the fragmentation methods can be provided upon request. A representative chromatogram for the UPLC-MS/MS analysis of the ASBC tetrahydro iso-α acid standard (ICS-T2) can be seen in Figure SI -1, with a table of fragmentations and relative retention times (Table SI- All countercurrent chromatography (CCC) experimentation was conducted using a J-type synchronous three-coiled planetary motion CCC-1000 (PharmaTech Research Corp.) as the column; this instrument possesses 810 mL of total column volume. This CCC column was coupled with Shimadzu preparative liquid chromatography instrumentation. Standard protocols for CCC were used over the course of the experimentation , [S4-S6] and specific details of the methods used can be found in Table SI -5. [S7,S 9] Further information is available upon request. In a separate flask, 141g (0.12 mol) of β-cyclodextrin were mixed with 1.1L of water and heated to 70 °C with mixing until the solution became homogenous/ translucent. The two solutions were slowly combined using a dropping funnel over 30 minutes. Following full addition, the mixture was removed from heat and allowed to come to room temperature at which point it was transferred to 4 °C storage for a period of 3 days. A precipitate formed during chill stabilization, and the supernatant was separated using centrifugation (1000 g, 10 minutes, 4 °C). The pellet was washed with 500 mL of water and the centrifugation was repeated; both aqueous supernatants were combined in a 4L separatory funnel. Ethanol (800 mL) was added to the supernatant, followed by 100mL of 1N HCl to bring the pH to ~1; without the ethanol a difficult emulsion forms. The supernatant was extracted three times with 200mL of hexanes and the extract was subsequently washed with water and brine to remove any residual β-cyclodextrin. Water (50mL) and 9.2M KOH (0.08mol, 10mL) were added in order to adjust to pH >8, followed by extraction of the organic layer three times with water (50 mL each time). The aqueous extract was collected in a 500mL Erlenmeyer flask and with vigorous stirring 12.4g (0.10 mol) of magnesium sulfate were slowly added to form a shelf-stable magnesium salt precipitate with the cis iso-α acids. The precipitate was collected via vacuum filtration, further dried via lyophilization and 21g were stored for future use. The yield and diastereoselectivity can be adjusted based on the equivalents of cyclodextrin used. [S8] SI2.1.2 Catalytic Hydrogenation Isohumulone (~700 mg, 2 mmol) was mixed with water and one equivalent of KOH (1.25 M aq. solution); a clear solution formed. To this solution was added an aqueous solution of magnesium sulfate (1.2 eq). A precipitate formed immediately, which was filtered, washed with water and dried on high vacuum overnight. This material was dissolved in methanol, 10% Pd on carbon was added (0.1 eq) and the reaction mixture was stirred under hydrogen (1 atm) until reaction completion (typical reaction time of 2 hours). After reaction completion, the catalyst was filtered off and the solvent was evaporated; this magnesium salt is well suited for storage. To liberate the free acid, material was suspended in 1M aq. HCl and the free acid was extracted to dichloromethane, the resulting dichloromethane extract was dried with sodium sulfate and evaporated. Alternatively, isohumulone was dissolved in methanol and 1 equivalent of magnesium oxide was added. The resulting mixture was stirred for 30 minutes at which time most of the magnesium oxide dissolved. To this mixture was added Pd catalyst and the same steps as in the previous procedure were followed. The yield for either hydrogenation reaction typically ranges between 80-95%.
SI2.1.3 Differential pH Extraction
Hops CO 2 extract (101g,~0.16 mol of alpha acids) was dissolved in 100mL of dichloromethane in a 250mL Erlenmeyer flask. When the solution was homogeneous, it was transferred to a 1L separatory funnel and the flask was washed with an additional 100mL of dichloromethane. Water (200mL) was added to the separatory funnel along with 10mL (0.09mol) of 9.2 M KOH to bring the aqueous solution to pH 8. The organic layer was extracted twice with 200mL of water. An additional 200mL of water and 4mL (0.04mol) of 9.2M KOH were added and the pH was maintained at approximately 8.5. The final 200mL aqueous extraction used 5mL (0.05mol) of 9.2M KOH, for a total of 0.18 moles of KOH or approximately 1.1eq relative to the alpha acids presumed present in the extract. The aqueous extracts were combined and back-extracted one time to remove any excess beta acids. The dicholoromethane solutions were combined and concentrated in vacuo to produce a mixture of beta acids and essential hop oils. The aqueous extract was acidified to pH 2 using sulfuric acid and extracted three times with 100mL of dichloromethane, concentrated in vacuo to isolate 70g of alpha acids in ≥98% homogeneity in an apparent quantitative yield.
SI2.2 Specific Preparations

SI2.2.1 Preparation of 1:
Cis tetrahydro isohumulone was purified using countercurrent chromatography (CCC) according to a reported procedure from a commercially available hops extract. [S7] Analytical data confirmed ≥95% homogeneity following CCC purification. 36, 21.41, 21.42, 21.45, 21.49, 24.36, 25.68, 27.32, 27.95, 31.77, 35.30, 36.37, 45.80, 50.42, 87.28, 110.34, 196.81, 199.57, 204.78, 210.78; The purified material was converted to the potassium salt by reaction with 1 equivalent of potassium hydroxide, and was recrystallized from water to increase purity and remove discoloration. After achieving sufficient homogeneity, the potassium salt was further recrystallized to render crystals of sufficient dimension for X-ray diffraction experiments. Potassium salt (+1a): Anal. Found: C, 61.79, H, 8.18, K 9.28. C16H27O43 K8 requires C, 61.23, H, 8.27, K, 9.50. m.p. 141 °C, optical rotation +71.5, c=1.0, MeOH Water (450 µL) and (+)-cis tetrahydro isohumulone potassium salt (49.5 mg) were added to a 4 mL vial, and the vial was sealed with a cap and heated using a thermal heating block (70°C) until dissolution occurred. The solution was allowed to cool to 35 °C over a two hour period. During this time, in situ formation of crystals was observed. The mixture was allowed to stand at room temperature (22 °C) for eight hours, at which point the formation of additional crystals was observed. An individual crystal suitable for X-ray analysis was identified, carefully removed from solution, mounted, and submitted for X-ray diffraction analysis.
SI2.2.2 Preparation of (-1):
(-)-cis tetrahydro isohumulone: ((4R,5S)-3,4-dihydroxy-2-(3methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one). A mixture of alpha acids (65 g) was dissolved in 200ml of limonene, bubbled with Ar for 30 min and heated at 145 °C for 120 minutes, at which point the reaction mixture was cooled to 50 °C, solvent was evaporated and the degree of racemization was evaluated and found to be 3% ee (enantiomeric excess). The racemic alpha acids were isolated using lead-acetate precipitation procedure [S3] and further purified by CCC using the procedure outlined in Table S -5. 4 (±)-Humulone (4.34 g, 12.0 mmol) was dissolved in 200mL of isopropanol and stirred. (1R,2R)-4-Cyclohexene-1,2-diamine (1.41g , 12.6 mmol) was added slowly to the racemic mixture. Crystals began forming within 1 hour at room temperature, and the mixture was placed in the refrigerator overnight (4 °C chill-stabilization). The crystals were collected via filtration, and were found to be enriched in (-)-humulone (35% ee). The mother liquor was concentrated in vacuo, followed by the addition of 20mL of isopropanol for further recrystallization in order to recover additional (-)-humulone (35% ee) and enrich the mother liquor in (+)-humulone (85% ee). (+)-Humulone (1.43g , 4.0mmol) was combined with 1.0 mL of water and heated to 81 °C. While the mixture stirred, 273mg (2.3mmol) of magnesium sulfate were added followed by the slow addition of 430µL (4.0mmol) of 9.2M KOH to form a hard resin precipitate. The mixture was heated and stirred for a total of 7 hours at approximately 80 °C. Upon completion, the water was removed via pipette from the vial (leaving the resinous precipitate), and 10mL of methanol was used to dissolve the remaining material. Magnesium oxide (256mg) was added and the mixture was stirred and filtered on a 0.2µm syringe filter into 2 separate and equal volume stocks. Stock 1 had 34mg of additional magnesium oxide and 200mg of 10% Pd/C added, and it was stirred under hydrogen (1 atm) for 1 hour. Stock 2 had 47mg of magnesium oxide and 187mg of 10% Pd/C added, and it was stirred for 2.5 hours under hydrogen (1 atm). The pH was brought to 1-2 using sulfuric acid, and the resulting mixture was filtered to remove any precipitates. Following CCC purification, [S7] 351mg (1.0 mmol, 25% yield from (+)-humulone) of (-)-cis tetrahyrdo isohumulone) was isolated for crystallization. Analytical data confirmed the purified material to be ≥95% (-)-cis tetrahydro isohumulone. The purified material was converted to a potassium salt by reacting with 1 equivalent of potassium hydroxide, and was recrystallized from water to increase purity. After achieving sufficient homogeneity, the potassium salt was further recrystallized to render crystals of sufficient dimension for X-ray diffraction experiments. Potassium salt (-1a): Anal. Found (Calc for 8M+3 H2O, formula corresponding to crystal structure): C61.42, H, 8.67. C 168 H 270 O 43 K 8 requires C, 61.32, H, 8.27. m.p. 143 °C, optical rotation -60.5, c=1.0, MeOH Water (110 µL) and the potassium salt of (-)-cis tetrahydro isohumulone (11.7 mg) were added to a 4 mL vial, the vial was sealed with a cap and heated using a thermal heating block (56°C) until dissolution occurred. The solution was allowed to cool to 43 °C for a few hours and a seed crystal was used to induce crystallization. The mixture was allowed to stand at room temperature (22 °C) until taken for X-ray analysis. An individual crystal suitable for X-ray analysis was identified, carefully removed from solution, mounted, and submitted to X-ray diffraction analysis.
SI2.2.3 Preparation of 2:
(+)-cis tetrahydro isocohumulone: (4S,5R)-3,4-dihydroxy-5-(3methylbutyl)-4-(4-methylpentanoyl)-2-(2-methylpropanoyl)cyclopent-2-en-1-one
The trans iso-α-acids were removed via β-cyclodextrin complexation (found in the generalized procedures section, [S8] from 45g of a hops isomerized resin extract. The cis material was further purified via CCC 9 in order to isolate cis isocohumulone. Cis isocohumulone was reduced via catalytic hydrogenation and repurified via CCC [S7] to ≥95% homogeneity. Free acid: Anal. Found: C, 68. 09, H, 9.11. C 20 H 32 O 5 requires C, 68.15, H, 9.15. m.p. 49-50 °C (50-52 °C) , optical rotation +35.3, c=1.0, MeOH (35.6) [S1] Cinchonidine salt of (+)-cis tetrahydro isocohumulone: (4S,5R)-3,4-dihydroxy-5-(3methylbutyl)-4-(4-methylpentanoyl)-2-(2-methylpropanoyl)cyclopent-2-en-1-one 1 Equivalent of each of (+)-cis tetrahydro isocohumulone (77.0 mg) and (-)-cinchonidine (51.9 mg, 1.00 eq.) were mixed in i Pr-OH (200 uL) and briefly heated to form a solution. t BuOMe ( 200 uL) was added and the resulting solution was left to crystallize at room temperature. Following three days at room temperature, the in situ formation of crystals was observed in this solution. An individual crystal suitable for X-ray analysis was identified, carefully removed, mounted and submitted for X-ray diffraction analysis. Cinchonidine salt (2b) 
SI2.2.4 Preparation of 3: (+)-cis tetrahydro isoadhumulone:
The trans iso-α-acids were removed via β-cyclodextrin complexation (found in the generalized procedures section, [S8] from 45g of a hops isomerized resin extract. The remaining cis material was further purified via CCC (9) in order to isolate cis isoadhumulone. Cis isoadhumulone was then reduced via catalytic hydrogenation and purified via CCC [S7] to ≥95% homogeneity. Cinchonidine salt of (+)-cis tetrahydro isoadhumulone (4S,5R)-3,4-dihydroxy-2-[(2S)-2methylbutanoyl]-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one 1 Equivalent each of (+)-cis tetrahydro isoadhumulone (50.0 mg) and (-)-cinchonidine (39.9 mg, 0.99 eq.) was added to i Pr-OH (200 uL) in a 4 ml amber colored vial and briefly heated (in a heating block set at 60-70 °C) to form a solution. Ether (200 uL) was added and the solution was left to form crystals at room temperature. The solution was sealed under a septum. The septum was pierced with a (Gauge16) needle to enable a gradual evaporation of solvent. Following three days at room temperature, the in situ formation of crystals was observed in this solution. An individual crystal suitable for X-ray analysis was identified, carefully removed, mounted and submitted for X-ray diffraction analysis. Cinchonidine salt (3b) 
SI2.2.5 Preparation of 4:
(+)-cis isohumulone: (4S,5R)-3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbut-2-en-1-yl)-4-(4-methylpent-3-enoyl)cyclopent-2-en-1-one Hops isomerized resin extract (45g) had the transiso-α-acids removed via β-cyclodextrin complexation (found in the generalized procedures section. 8 The remaining cis material was further purified via CCC [S7] in order to isolate cis isohumulone confirmed to be ≥95% homogeneous following purification. Cinchonidine salt of (+)-cis isohumulone: (4S,5R)-3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3methylbut-2-en-1-yl)-4-(4-methylpent-3-enoyl)cyclopent-2-en-1-one 1 Equivalent each of (+)-cis isohumulone (99.4 mg) and (-)-cinchonidine (80.0 mg, 0.99 eq.) was mixed in i Pr-OH (100 uL) and briefly heated to form a solution. t BuOMe ( 500 uL) was added and the solution was left to form crystals at room temperature. Following three days at room temperature, the in situ formation of crystals was observed in this solution. An individual crystal suitable for X-ray analysis was identified, carefully removed, mounted and submitted for X-ray diffraction analysis. Cinchonidine salt (4b) 
SI2.2.6 Preparation of 5:
(-)-humulone: (6S)-3,5,6-trihydroxy-2-(3-methylbutanoyl)-4,6-bis(3methylbut-2-en-1-yl)cyclohexa-2,4-dien-1-one (-)-Humulone (5) was isolated from commercially available hops CO 2 extract via a differential pH extraction, (found in the generalized procedures section), followed by CCC purification of the resultant alpha acid fraction [S10] to ≥95% homogeneity. m.p. 66 °C (66 °C), [S1] optical c=1.0, [S1] (1R,2R)-(-)-diaminocyclohexane salt of (-)-humulone: (6S)-3,5,6-trihydroxy-2-(3methylbutanoyl)-4,6-bis(3-methylbut-2-en-1-yl)cyclohexa-2,4-dien-1-one 6.0 mg of (-)-N-humulone was mixed with (1R,2R)-(-)-diaminocyclohexane in MeOH. Solution was evaporated and redissolved in tBuOMe. It was left to evaporated slowly over several days, while crystals were formed. 1,2-Diamincyclohexane salt (5c): Anal. Found: C 68. 05, H 9.56, N, 5.77. C 27 H 44 N 2 O 5 requires C, 68.05, H, 9.30, N, 5.88. m.p. 144 °C.
SI2.2.7 Preparation of 6:
(-)-trans tetrahydro isohumulone: ((4S,5S)-3,4-dihydroxy-2-(3methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one) The alpha acids were isolated from a commercially available hops CO 2 extract via a differential pH extraction (found in the generalized procedures section). A 450mm jacketed borosilicate glass immersion well was wrapped with approximately 17 meters of 2.7mm inner diameter FEP tubing and was used with a 450W medium pressure mercury immersion lamp to produce a flow photoreactor. [S11] The isolated alpha acids (2.1g) were dissolved in 100mL of methanol and run through the flow reactor at 5mL/min, for 2 hours, recycling the effluent until the reaction was complete. The resulting free acid mixture of trans-iso-α-acids was reduced via catalytic hydrogenation and purified via CCC to produce trans tetrahydro isohumulone [S7] in ≥95% homogeneity. Free acid: Anal. Found: C, 68. 05, H, 9.56, N, 5.77. C 27 H 44 N 2 O 5 requires C, 68.04, H, 9.30, N, 5.88. m.p. 76 °C (78-81 °C) , [S1] optical rotation -11.2, c=1.0, MeOH (-12.4) [S1] 1 H NMR (500 MHz, METHANOL-d 4 ) δ ppm 0.88 -0.95 (m, 12 H) 0.98 (dd, J=16.30, 6.68, Hz, 6 H) 26, 21.31, 21.36, 21.37, 21.49, 21.58, 22.19, 26.28, 27.25, 27.93, 31.35, 36.70, 37.04, 44.14, 47.10, 47.27, 47.44, 47.61, 47.79, 47.95, 48.12, 191.45, 196.44, 207.67, 210.23 ; Cinchonine salt of (-)-trans tetrahydro isohumulone (6d): ((4S,5S)-3,4-dihydroxy-2-(3methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one) (-)-Trans tetrahydro isohumulone (54.3 mg) was mixed with cinchonine (43.0 mg, 1 eq) in MeOH and the resulting solution was evaporated. The resulting solid salt was suspended in hexane and chloroform was added until complete dissolution occurred. The solution was left open to allow the solvent to slowly evaporate over several days, at which time crystals formed. An individual crystal suitable for X-ray analysis was identified, carefully removed, mounted and submitted to X-ray diffraction analysis. The remaining crystals were filtered, dried at high vacuum and submitted for elemental analysis. Cinchonine salt: Anal. Anal. (Calc. as M+0.15CHCl 3 ) Found: C71.26, H, 8.35, N, 4.15. C 40.15 H 56.1 Cl 0.45 N 2 O 6 requires C, 71. 04, 8.34, N, 4.13. m.p. 137-139 °C.
SI3. X-RAY STRUCTURES Methodology and instrumentations
Colorless crystals of about one-third of a mm in diameter were mounted on glass capillaries with oil. Data were collected on a Bruker APEX II single crystal X-ray diffractometer, Mo-radiation (collection temperature, see Table SI6 ). Crystal-to-detector distance was 40 mm and exposure time was 10 to 120 seconds per degree for all sets. The scan width was 0.5 o . Data collection completeness to 25 o in ϑ was above 98% in all cases. Further details are given in Table SI-6 below. The data were integrated and scaled using SAINT, SADABS within the APEX2 software package by Bruker . [S12] Solution by direct methods (SHELXS, SIR97) [S13,S14] produced a complete heavy atom phasing model consistent with the proposed structure. The structures were completed by difference Fourier synthesis with SHELXL97 [S15,S16] Scattering factors are from Waasmair and Kirfel. [S17] Hydrogen atoms were placed in geometrically idealised positions and constrained to ride on their parent atoms with C---H distances in the range 0.95-1.00 Angstrom. Isotropic thermal parameters (U eq ) were fixed such that they were 1.2U eq of their parent atom's Ueq for CH's and 1.5U eq of their parent atom's U eq in the case of methyl groups. All nonhydrogen atoms were refined anisotropically by full-matrix least-squares. The weighting schemes were optimized by the values suggested by SHELXL after each refinement. CCDC 913165 -913171 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. SI3.1 X-ray structure of Compound +1a, potassium salt of (+)-cis n-tetrahydro iso α α α α-acid
This structure, described in [S2] is added for completion. The asymmetric unit for this structure consists of 4 negatively charged molecules of (1) coordinating with 4 potassium cations. Two potassiums are bridged by a single water molecule, another disordered water coordinates with the remaining two cations. Ketones of the organic moieties coordinate with the cations leading to a close packing pattern. The absolute configuration was obtained from anomalous scattering (Absolute structure parameter = 0.04(4)) Figure SI-3. ORTEP representations of the asymmetric unit in the structure for compound 1 with displacement ellipsoids at the 50% probability level. 
The four different anions of compound 1 found in this structure, exhibiting different conformation of the same chirality.
SI3.2 X-ray structure of Compound -1a, potassium salt of (-)-cis n-tetrahydro iso α α α α-acid Details of the structure for compound (2) are similar to that of (1), except that it possesses the opposite handedness. One disordered t BuOMe molecule was found in addition to the four molecules shown below, the disorder of which causes further disorder in the structure (not demonstrated in Figures SI-7 or SI-8). The structure in SI-9 with details in SI-10 contains disordered ether and isopropyl alcohol at a ratio 28:72 per two salts. The absolute configuration was obtained from comparing the (-) cinchonidine cation to the known absolute configuration. Several hydrogen bonds are observed which hold this salt structure together (Table SI- 8) . The absolute configuration was obtained from comparison with the known (-)-cinchonidine for assignment. (7) 158.6 ____________________________________________________________________________ Symmetry transformations used to generate equivalent atoms: #1 -x,y-1/2,-z+1 #2 -x,y+1/2,-z+1
Figure SI-11. ORTEP representations of the asymmetric unit in the structure for compound 4b with displacement ellipsoids at the 50% probability level.
SI3.6 X-ray structure of Compound 5c, (-)-humulone * (1R, 2R)-1,2-diaminocyclohexane
Upon cooling, the thin and very fragile needle shaped crystals of 5c disintegrated, where cause and exact temperature for the problem are not known. We thus choose to collect the data at room temperature (19.4 o C) which then left us with less scattering, more diffuse background and hence, unsatisfying statistical data agreement factors (R int ). The salt ( Figure SI-12 ) exhibits several hydrogen bonds (Table SI-9) , notably inter-molecularly O1-N1, intra-molecularly O3-O5, N2-O4. Chiral centers: C22: R, C27: R (reference molecule with known chirality), C1: S. (9) 152.0 ____________________________________________________________________________ Symmetry transformations used to generate equivalent atoms: #1 x+1,y,z #2 x-1/2,-y+1/2,-z #3 x+1/2,-y+1/2,-z Figure SI-12. ORTEP representations of the asymmetric unit in the structure for compound 5c with displacement ellipsoids at the 50% probability level. SI3.7 X-ray structure of Compound 6d, (-)-trans-iso α α α α-acid * cinchonine
The absolute structure was first set to match the known enantiomer of (+) cinchonine. The presence of chloroform (disorder of which not shown in Fig. SI-13 ) allowed the use of anomalous scattering to determine the absolute structure. The correct assignment was confirmed by the Flack-enantiopole parameter of 0.02(6).
Figure SI-13. ORTEP representations of the asymmetric unit in the structure for compound 6d with displacement ellipsoids at the 50% probability level. Disorder of solvent omitted for clarity.
